Back to search results
NCT05520983

BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental Disabilities (IDD)

Enrolling by Invitation
NAAges 13–20InterventionalHealth services
University of Illinois at Chicago
~780 participants
Updated 2025-03-07 on ClinicalTrials.gov
What's tested:Adapted Teens Achieving Mastery over Stress (TEAMS) TreatmentAdapted Teens Achieving Mastery over Stress (TEAMS) PreventionAdapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT)Strengthening FamiliesVirtual psycho-educational discussion groups for caregivers and participantsMaternal Child Health Bureau (MCHB) Care Coordination

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Depressive Symptomatology
Measured over Baseline through 24 months
+5 more outcomes measured

Conditions

Depression
Anxiety
Transition

Explore related trials

AnxietyDepressionIntellectual and Developmental Disabilities

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Kristin L Berg, PhD · PRINCIPAL_INVESTIGATOR · University of Illinois at Chicago
  • Benjamin W Van Voorhees, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Illinois at Chicago
  • Iulia Mihaila, PhD · STUDY_DIRECTOR · University of Illinois at Chicago

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Depressive SymptomatologyBaseline through 24 months

    The Patient Health Questionnaire Youths (PHQ-A) is a 9-item self-report measure of depressive symptomatology that has been shown to be both valid and reliable (α=.86-.89) (4-point Likert scale, 0-27 score range, higher score indicating more depressive symptoms/severity).This instrument has been used to assess depression in individuals with Autism Spectrum Disorder (ASD), cystic fibrosis and other I/DD.

  • Depressive Symptomatology (additional measures for those participating in Tiers 2 and 3)Baseline through 24 months

    The Patient Health Questionnaire 8 (PHQ-8) is an 8-item self-report measure of depressive symptomatology that has been shown to be both valid and reliable (4-point Likert scale, 0-24 score range, higher score indicating more depressive symptoms/severity). This instrument is a version of the PHQ-9 that does not include a question regarding suicidality. Participants in Group B, Tier 2 will receive this instrument during the course of the Tier 2 intervention (online group sessions). Participants in Group B, Tier 3 will receive this instrument during the course of the Tier 3 intervention (online group sessions).

  • Anxiety SymptomatologyBaseline through 24 months

    The Generalized Anxiety Disorder (GAD-7) is a 7-item measure of anxiety symptomatology (4-point Likert scale, 0-21 score range, higher score indicating greater anxiety severity) that has been shown to be both valid and reliable (α=.92) and has been used to assess anxiety in individuals with ASD and other I/DD. Additionally, participants in Group B, Tier 2 will receive this instrument during the course of the Tier 2 intervention (online group sessions). Participants in Group B, Tier 3 will receive this instrument during the course of the Tier 3 intervention (online group sessions).

  • Major Depression Disorder and Anxiety DisorderBaseline through 24 months

    The Mini-International Neuropsychiatric Interview for Children and Youths (MINI Kid) is a structured diagnostic interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) and International Classification of Diseases, Tenth Revision (ICD-10) psychiatric disorders in children and adolescents. The 72-item (yes/no response choices) sub-scales to identify depression and anxiety disorders will be utilized. These scales have been found to be both valid and reliable, and have been used with individuals with ASD and other I/DD.

  • Depressive Symptomatology of CaregiverBaseline through 24 months

    The Patient Health Questionnaire (PHQ-9) is a 9-item adult-report measure of depressive symptomatology (4-point Likert scale, 0-27 score range, higher score indicating more depressive symptoms/severity) that has shown to be valid and reliable (α=.86-.89).

  • Anxiety Symptomatology of CaregiverBaseline through 24 months

    The Generalized Anxiety Disorder (GAD-7) is a 7-item measure of anxiety symptomatology (4-point Likert scale, 0-21 score range, higher score indicating greater anxiety severity) that has been shown to be both valid and reliable (α=.92).